{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:51:26Z","timestamp":1785847886838,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":73,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.prp.2023.154540","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:09:08Z","timestamp":1684361348000},"page":"154540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis"],"prefix":"10.1016","volume":"247","author":[{"given":"Sofia","family":"Melotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giunchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia Di","family":"Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Mineo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Martin","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154540_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083585","article-title":"Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines","volume":"9","author":"Eini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154540_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2332","article-title":"Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications","volume":"215","author":"de Jong","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2023.154540_bib3","doi-asserted-by":"crossref","first-page":"47095","DOI":"10.18632\/oncotarget.9903","article-title":"SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate","volume":"26","author":"Nettersheim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154540_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2012.08.030","article-title":"Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells","volume":"48","author":"Lin","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2023.154540_bib5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/nar\/gkm059","article-title":"Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3\/4 target genes","volume":"35","author":"Boer","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2023.154540_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/ijc.32714","article-title":"Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate","volume":"146","author":"Jostes","year":"2020","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2023.154540_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/(SICI)1098-2795(199808)50:4<377::AID-MRD1>3.0.CO;2-F","article-title":"Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells","volume":"50","author":"Johnson","year":"1998","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.prp.2023.154540_bib8","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1158\/1078-0432.CCR-09-3338","article-title":"DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma","volume":"16","author":"Minami","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154540_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00428-021-03168-5","article-title":"Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors","volume":"479","author":"Miyai","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.154540_bib10","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.3390\/ijms21124487","article-title":"Meta-analysis of gene expressions in testicular germ cell tumor histologies","volume":"21","author":"von Eyben","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154540_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/bjc.2016.187","article-title":"The cancer\/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas","volume":"115","author":"Nettersheim","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154540_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.2016.217","article-title":"PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers","volume":"115","author":"Neuhaus","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154540_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/biolre\/ioab074","article-title":"The PRAME family of cancer testis antigens is essential for germline development and gametogenesis","volume":"105","author":"Kern","year":"2021","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.prp.2023.154540_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12770","article-title":"The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer","volume":"53","author":"Xu","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.prp.2023.154540_bib15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/jcmm.16222","article-title":"The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours","volume":"25","author":"Wruck","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2023.154540_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ajcp\/aqab200","article-title":"Immunohistochemical expression of preferentially expressed antigen in melanoma (PRAME) in the uninvolved background testis, germ cell neoplasia in situ, and germ cell tumors of the testis","volume":"157","author":"Ricci","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2023.154540_bib17","article-title":"SOX2 and PRAME in the \"reprogramming\" of seminoma cells","volume":"237","author":"Orsatti","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.154540_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1034\/j.1600-0463.2003.1110131.x","article-title":"Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis","volume":"111","author":"Oosterhuis","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.prp.2023.154540_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4161\/cbt.10.6.13227","article-title":"The role of microenvironment in testicular germ cell tumors","volume":"10","author":"D\u00edez-Torre","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2023.154540_bib20","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jcmm.13082","article-title":"The plasticity of germ cell cancers and its dependence on the cellular microenvironment","volume":"21","author":"Nettersheim","year":"2017","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2023.154540_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/cells11050885","article-title":"A coculture model mimicking the tumor microenvironment unveils mutual interactions between immune cell subtypes and the human seminoma cell line TCam-2","volume":"11","author":"Gayer","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154540_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies","volume":"41","author":"Kumari","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154540_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2023.154540_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2023.154540_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.874589","article-title":"Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression","volume":"13","author":"Pu","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2023.154540_bib26","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","article-title":"Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer","volume":"11","author":"Nixon","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2023.154540_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.573977","article-title":"Immunotherapy in testicular germ cell tumors","volume":"10","author":"Kalavska","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2023.154540_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858797","article-title":"Comprehensive assessment of selected immune cell subpopulations changes in chemotherapy-na\u00efve germ cell tumor patients","volume":"12","author":"Kalavska","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2023.154540_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ajcp\/aqz184","article-title":"Differences in PD-L1-expressing macrophages and immune microenvironment in testicular germ cell tumors","volume":"153","author":"Sadigh","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2023.154540_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920954802","article-title":"Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study","volume":"12","author":"Ricci","year":"2020","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.prp.2023.154540_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-019-09601-5","article-title":"Prognostic impact of MCPyV and TIL subtyping in merkel cell carcinoma: evidence from a large European cohort of 95 patients","volume":"31","author":"Ricci","year":"2020","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.prp.2023.154540_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2326-6066.CIR-13-0034","article-title":"PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival","volume":"1","author":"Lipson","year":"2013","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.prp.2023.154540_bib33","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/1078-0432.CCR-16-0392","article-title":"Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma","volume":"22","author":"Feldmeyer","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154540_bib34","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2023.154540_bib35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2019.08.023","article-title":"PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer","volume":"136","author":"Sumitomo","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2023.154540_bib36","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s00262-022-03187-4","article-title":"The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma","volume":"11","author":"Shinchi","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.prp.2023.154540_bib37","unstructured":"WHO Classifications of Tumors Editorial Board. Urinary and male genital tumours, Fifth ed., IARC Press, Lyon, 2022."},{"key":"10.1016\/j.prp.2023.154540_bib38","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.prp.2023.154540_bib39","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3390\/cancers11101535","article-title":"Detailed characterization of immune cell infiltrate and expression of immune checkpoint molecules PD-L1\/CTLA-4 and MMR proteins in testicular germ cell tumors disclose novel disease biomarkers","volume":"11","author":"Lobo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2023.154540_bib40","article-title":"Integrated molecular analysis reveals 2 distinct subtypes of pure seminoma of the testis","volume":"21","author":"Medvedev","year":"2022","journal-title":"Cancer Inf."},{"key":"10.1016\/j.prp.2023.154540_bib41","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2217\/epi-2018-0034","article-title":"DNA methylation profiling as a tool for testicular germ cell tumors subtyping","volume":"10","author":"Costa","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.prp.2023.154540_bib42","article-title":"Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors","volume":"8","author":"Boldrini","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2023.154540_bib43","doi-asserted-by":"crossref","first-page":"21794","DOI":"10.18632\/oncotarget.15585","article-title":"Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors","volume":"8","author":"Chovanec","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154540_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1305535","article-title":"Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling","volume":"6","author":"Siska","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2023.154540_bib45","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41374-020-0429-0","article-title":"Brightfield multiplex immunohistochemistry with multispectral imaging","volume":"100","author":"Morrison","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.prp.2023.154540_bib46","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/cancers14153682","article-title":"Bright-field multiplex immunohistochemistry assay for tumor microenvironment evaluation in melanoma tissues","volume":"14","author":"Ugolini","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:59:12Z","timestamp":1759733952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":46,"alternative-id":["S0344033823002406"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154540","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154540"}}